SAHPRA Tag

16 Feb Webinar on Increasing Awareness and Reporting of Medication Errors

Posted at 15:11h in

The South African Health Products Regulatory Authority (SAHPRA) hosted a conversation on what medication errors are and why it is vital that patients or healthcare professionals report them. We have invited panellists from two hospitals to share their knowledge, experience, and expertise to begin this important...

Read More

Photo by Maksim Goncharenok via Pexels

30 Jan SAHPRA registers Paxlovid, an anti-viral medicine for COVID-19

Posted at 18:24h in News & Updates, Press Releases

Share

Pretoria, 30 January 2023 – The South African Health Products Regulatory Authority (SAHPRA) has registered Paxlovid, an anti-viral medicine manufactured by Pfizer, to treat COVID-19. Paxlovid, which contains Nirmatrelvir (150mg) and Ritonavir (100mg), is a medicine that is used for the treatment of mild to moderate...

Read More

Photo by Miguel Á. Padriñán via Pexels

09 Jan Radionuclides Annual Returns 2022 Update

Posted at 10:45h in Radiation Control

Share

09 January 2023 Note to Radionuclides Authority Holders The Annual Returns have been somewhat delayed and are now being sent out. It is a time-consuming process and will not be completed before 21 January 2023. Please await the prepopulated form for year-end 2022 (AR22) and do not resort...

Read More

Thirdman via Pexels

15 Dec Long Acting Cabotegravir, a preventative ARV for HIV

Posted at 13:06h in News & Updates

Share

Many of you have heard about this strange sounding medication, Cabotegravir (Cah-bot-er-grah-ver), floating around news broadcasts and print outlets. Well, this medication is a Human Immunodeficiency Virus (HIV) anti-retroviral (ARV) that has been recently approved by the South African Health Products Regulatory Authority (SAHPRA). What is...

Read More

Miguel Á. Padriñán via Pexels

02 Dec SAHPRA registers new long-acting HIV Pre-exposure prophylaxis

Posted at 15:34h in News & Updates, Press Releases

Share

Pretoria, 2 December 2022 – The South African Health Products Regulatory Authority (SAHPRA) has registered Cabotegravir (Apretude 600 mg/3ml injection), a long-acting HIV pre-exposure prophylactic. Cabotegravir is an antiretroviral drug (ARV) that people living with HIV may use, together with other ARVs, to keep the virus...

Read More

visionart.av via Pexels

02 Dec SAHPRA celebrates the conclusion of the backlog clearance project

Posted at 12:18h in News & Updates, Press Releases

Share

Pretoria, 2 December 2022 – With the establishment of the South African Health Products Regulatory Authority (SAHPRA) in February 2018, the regulatory authority inherited a backlog of approximately 16 000 new product and variation applications from its predecessor, the Medicines Control Council (MCC). As is generally...

Read More

visionart.av via Pexels

24 Nov SAHPRA approves antigen self-test kits for public use

Posted at 18:31h in News & Updates, Press Releases

Share

Pretoria, 24 November 2022 – In the past year, the South African Health Products Regulatory Authority (SAHPRA) approved the antigen test kits for use by healthcare professionals. SAHPRA has now approved seven (7) COVID-19 antigen self-test kits that can be used as self-test/ at home tests...

Read More

Ekaterina Bolovtsova via Pexels

23 Nov SAHPRA Statement – Latest Development on Ivermectin Court Case

Posted at 12:38h in News & Updates, Press Releases

Share

Pretoria, 23 November 2022 – On 6 April 2021, the Pretoria High Court issued a consent court order pertaining to four cases that were brought against the South African Health Products Regulatory Authority (SAHPRA) and the Minister of Health regarding access to Ivermectin for use...

Read More

Mat Napo via Unsplash

22 Nov SAHPRA registers COMIRNATY’s paediatric and adult vaccines

Posted at 15:35h in News & Updates, Press Releases

Share

22 November 2022 Embargo: Immediate release Pretoria, 22 November 2022 - The South African Health Products Regulatory Authority (SAHPRA) has registered Pfizer’s COMIRNATY Ready To Use (RTU) ADULT VACCINE and Dilute To Use (DTU) PAEDIATRIC VACCINE on 15 November 2022. The RTU vaccine, as the name...

Read More

© SAHPRA

22 Nov Face to Face: Prof Helen Rees on SAHPRA, women’s rights, and her appetite for justice

Posted at 09:00h in News & Updates

Share

Pretoria, 21 November 2022 – As a rebellious teenager growing up in the British town of Harpenden, Helen Rees would sneak out to attend anti-apartheid talks. “That was the stop-the-Boks tour,” she recalls. “[British politician] Peter Hain was an activist trying to stop the Springboks...

Read More